Cutaneous lymphoid hyperplasia treated with rituximab: Report of 4 patients

(2016) Cutaneous lymphoid hyperplasia treated with rituximab: Report of 4 patients. Journal of Isfahan Medical School. ISSN 10277595 (ISSN)

Full text not available from this repository.

Abstract

Background: Cutaneous benign lymphoid hyperplasia (CLH) is a B-cell pseudolymphoma of unknown origin and the most involving site is the face. Case Report: This report presents 4 CLH patients treated with rituximab. Conclusion: Rituximab may be useful for resistant or relapsing forms of CLH who failed other forms of therapy. © 2016. Isfahan University of Medical Sciences(IUMS). All rights reserved.

Item Type: Article
Keywords: Cutaneous lymphoid hyperplasia Rituximab Treatment Article case report human lymphoid hyperplasia skin disease
Journal or Publication Title: Journal of Isfahan Medical School
Journal Index: Scopus
Volume: 34
Number: 371
ISSN: 10277595 (ISSN)
Depositing User: مهندس مهدی شریفی
URI: http://eprints.mui.ac.ir/id/eprint/4164

Actions (login required)

View Item View Item